Current Advances in Hypertrophic Scar and Keloid Management

被引:40
|
作者
Barone, Natasha [1 ]
Safran, Tyler [2 ]
Vorstenbosch, Joshua [2 ]
Davison, Peter G. [2 ]
Cugno, Sabrina [2 ]
Murphy, Amanda M. [2 ,3 ]
机构
[1] McGill Univ, Fac Med & Hlth Sci, Montreal, PQ, Canada
[2] McGill Univ, Div Plast & Reconstruct Surg, Hlth Ctr, Montreal, PQ, Canada
[3] Jewish Gen Hosp, Div Plast & Reconstruct Surg, Montreal, PQ, Canada
关键词
scarring; fibrosis; keloid; hypertrophic scar; IMIQUIMOD 5-PERCENT CREAM; INTERNATIONAL CLINICAL RECOMMENDATIONS; PAPER TAPE; INTRALESIONAL; 5-FLUOROURACIL; SURGICAL EXCISION; RECURRENCE-RATES; CONTROLLED-TRIAL; LASER TREATMENT; ONION EXTRACT; PREVENTION;
D O I
10.1055/s-0041-1731461
中图分类号
R61 [外科手术学];
学科分类号
摘要
Hypertrophic scars and keloids are caused by excessive tissue response to dermal injury due to local fibroblast proliferation and collagen overproduction. This response occurs because of pathologic wound healing due to dysregulation in the inflammatory, proliferative, and/or remodeling phase. Patients with hypertrophic scars or keloids report reduced quality of life, physical status, and psychological health. Hypertrophic scars or keloids will develop in 30 to 90% of individuals, and despite their prevalence, treatment remains a challenge. Of the treatments currently available for hypertrophic scars and keloids few have been adequately supported by studies with appropriate experimental design. Here, we aim to review the available literature to provide up-to-date information on the etiology, epidemiology, histology, pathophysiology, prevention, and management options available for the treatment of hypertrophic scars and keloids and highlight areas where further research is required.
引用
收藏
页码:145 / 152
页数:8
相关论文
共 50 条
  • [11] Keloid or hypertrophic scar - The controversy: Review of the literature
    Atiyeh, BS
    Costagliola, M
    Hayek, SA
    ANNALS OF PLASTIC SURGERY, 2005, 54 (06) : 676 - 680
  • [13] MORPHOLOGICAL AND IMMUNOCHEMICAL DIFFERENCES BETWEEN KELOID AND HYPERTROPHIC SCAR
    EHRLICH, HP
    DESMOULIERE, A
    DIEGELMANN, RF
    COHEN, IK
    COMPTON, CC
    GARNER, WL
    KAPANCI, Y
    GABBIANI, G
    AMERICAN JOURNAL OF PATHOLOGY, 1994, 145 (01): : 105 - 113
  • [14] COLLAGEN DEGRADATION IN CULTURED KELOID AND HYPERTROPHIC SCAR TISSUE
    MILSOM, JP
    CRAIG, RDP
    BRITISH JOURNAL OF DERMATOLOGY, 1973, 89 (06) : 635 - 644
  • [15] Differential expression of cyclooxygenases in hypertrophic scar and keloid tissues
    Rossiello, Luigi
    D'Andrea, Francesco
    Grella, Roberto
    Signoriello, Giuseppe
    Abbondanza, Ciro
    De Rosa, Caterina
    Prudente, Mariaevelina
    Morlando, Marianna
    Rossiello, Raffaele
    WOUND REPAIR AND REGENERATION, 2009, 17 (05) : 750 - 757
  • [16] A-GLOBULIN COLLAGENASE INHIBITORS IN KELOID AND HYPERTROPHIC SCAR
    COHEN, IK
    DIEGELMANN, RF
    BRYANT, CP
    SURGICAL FORUM, 1975, 26 : 61 - 62
  • [17] Keloid and hypertrophic scar treatment modalities. An update
    Branski, L. K.
    Rennekampff, H. O.
    Vogt, P. M.
    MKG-CHIRURG, 2013, 6 (02): : 117 - 130
  • [18] SCANNING ELECTRON-MICROSCOPY OF HYPERTROPHIC AND KELOID SCAR
    KEMBLE, JVH
    POSTGRADUATE MEDICAL JOURNAL, 1976, 52 (606) : 219 - 221
  • [19] Identification of the potential targets for keloid and hypertrophic scar prevention
    Zhang, Lianbo
    Qin, Haiyan
    Wu, Zhuoxia
    Chen, Wanying
    Zhang, Guang
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2018, 29 (06) : 600 - 605
  • [20] Keloid and hypertrophic scar treatment modalities. An update
    Branski, L. K.
    Rennekampff, H. O.
    Vogt, P. M.
    CHIRURG, 2012, 83 (09): : 831 - 844